Inventor
Alfred Weber
Inventor
Berlin, DE
Overview
Patents· 62 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Pprimary
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture14%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests12%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
A61KPreparations for medical, dental or toiletry purposes8%
C07KPeptides8%
C07JSteroids8%
B01DSeparation6%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C21CProcessing of pig-iron, e.g. refining, manufacture of wrought-iron or steel3%
F27DDetails or accessories of furnaces, kilns, ovens or retorts, in so far as they are of kinds occurring in more than one kind of furnace3%
PatentTitleYear
10,875,906Removal of serine proteases by treatment with finely divided silicon dioxide202010,738,107Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggs202010,208,106Removal of serine proteases by treatment with finely divided silicon dioxide20199,896,501'Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs'20189,708,391'Removal of serine proteases by treatment with finely divided silicon dioxide'20179,556,261'Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs'20179,547,016'Method and compositions for specifically detecting physiologically acceptable polymer molecules'20179,512,172'Ethanol dependence of alpha1 antitrypsin C-terminal Lys truncation by basic carboxypeptidases'20169,468,675'Removal of serine proteases by treatment with finely divided silicon dioxide'20169,274,122'Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)'20169,084,743'Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof'20159,075,069'Measurement of autoantibodies at low conductivity with increased sensitivity'20158,921,520'Removal of serine proteases by treatment with finely divided silicon dioxide'20148,889,838'Removal of serine proteases by treatment with finely divided silicon dioxide'20148,828,676'Methods for differentiating plasma-derived protein from recombinant protein in a sample'20148,785,139'Modification-dependent activity assays'20148,772,240'Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidases'20148,772,462'Removal of serine proteases by treatment with finely divided silicon dioxide'20148,652,793'Solid phase-bound elastase-binding assay for the measurement of alpha1-antitrypsin activity'20148,603,830'Method for the determination of polysorbate 80'20138,557,534'Method and compositions for specifically detecting physiologically acceptable polymer molecules'20138,114,633'Methods for differentiating plasma-derived protein from recombinant protein in a sample'20126,307,032'Highly purified factor VIII complex'20015,835,524'Scrap-melting electric arc furnace'19985,773,264'Process for the production of 17 .alpha.-hydroxy-3-methoxy-8,14-seco-1,3,5(10),9(11)estratetraen-14-one by reduction of the corresponding 17-one compound'19985,712,099'Process for the production of arabinonucleosides'19985,700,666'Process for the production of arabinonucleotides'19975,565,343'Process for the production of dulcitol from lactose'19965,558,142'Woodworking milling cutter particularly for grooving and profiling'19965,516,649'Process for the production of 4-androstene-3,17-dione and 1,4-androstadiene-3,17-dione from ergosterol with mycobacterium'19965,472,854'Process for the production of 17-oxosteroids via the fermentative oxidation of 17.beta.-hydroxysteroids by Mycobacterium'19955,429,934'Process for the production of 20-methyl-5,7-pregnadiene-3.beta.,21-diol derivatives using mycobacterium'19955,418,145'Process for the preparation of 4-androstene-3,17-dione and 1,4-androstadiene-3,17-dione'19955,391,484'Process for the production of 4-pregnene-3,20-dione and its derivatives using mycobacterium NRRL B-3805'19955,371,000'Process for the production of ergoline derivatives'19945,258,290'Fermentation process for the production of .beta.-carboline derivatives by Myrothecium verrucaria'19935,238,484'Plant for the production of molten metals and method'19935,190,719'Plant for the production of molten metals'19935,167,699'Process and installation for producing molten steel of scrap'19925,163,353'Energy saving and monitoring pneumatic control valve system'19925,100,782'Process for the preparation of L-amino acids and amino acid amides'19925,071,752'Process for the production of L-amino acids'19914,971,698'Process for wastewater purification'19904,968,610'Process for the preparation of chanoclavine'19904,939,089'Process for the preparation of festuclavine'19904,898,693'Process for production of 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl -4-pregnene-3,20-dione and its derivatives'19904,839,282'Preparation of 3-oxo-.DELTA..sup.1,4 -steroids'19894,836,510'Metallurgical plant'19894,792,123'Metallurgical plant'19884,644,067'Process for the extraction of amino acids from an aqueous phase'19874,431,732'Process for the preparation of 11.beta.,21-dihydroxy-2\'-methyl-5\'.beta.H-1,4-pregnadieno(16,17-D)-oxazo le-3,20-dione'19844,224,320'Novel steroids of the pregnane series, substituted in the 17-position, their manufacture and their use'19804,212,940'Process for the preparation of 21-hydroxy-20-methylpregnane derivatives'19804,207,316'Novel 17-substituted 11 .beta.-hydroxy steroids of the pregnane series, their manufacture, preparation and use'19804,179,336'Microbiological degradation of sterol side chains to a 17-keto group'19794,170,518'Microbiological conversion of sterol derivatives to 5-androsten-17-one derivatives and their use'19794,169,628'Panel for a seat'19794,138,779'Process and device for mounting a fastening element to a composite panel'19794,100,026'Process for the preparation of 4-androstene-3,17-dione derivatives'19784,100,027'Process for the preparation of 4-androstene-3,17-dione derivatives'19784,097,334'Process for the preparation of androstane-3,17-dione derivatives'19784,057,541'Method for isolation of 3-hydroxy steroids and 3-keto steroids'1977Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1977–1998Patents assigned to SCHERING AG (29)· patent assignee history
1977–1998Based in Berlin, DE· patent location history
1979Based in Schaffhausen, CH· patent location history
1988–1992Based in St. Georgen, AT· patent location history
1993–1998Based in Luftenberg, AT· patent location history
2001–2020Based in Vienna, AT· patent location history
2012–2015Patents assigned to BAXTER HEALTHCARE SA (12)· patent assignee history
2012–2015Patents assigned to BAXTER INT (12)· patent assignee history
2016–2020Patents assigned to BAXALTA INC (10)· patent assignee history
2016–2020Patents assigned to Baxalta GmbH (10)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCHERING AG | 29 | 1977–1998 |
| BAXTER HEALTHCARE SA | 12 | 2012–2015 |
| BAXTER INT | 12 | 2012–2015 |
| BAXALTA INC | 10 | 2016–2020 |
| Baxalta GmbH | 10 | 2016–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Berlin, DE | 29 | 1977–1998 |
| Vienna, AT | 23 | 2001–2020 |
| Luftenberg, AT | 3 | 1993–1998 |
| St. Georgen, AT | 2 | 1988–1992 |
| Schaffhausen, CH | 2 | 1979 |